ATAI Life Sciences
Manager, Corporate Finance
• Executed critical strategic projects across Corporate Development, Finance, Investor Relations and Strategy
• Led market landscaping, buy-vs.-partner analysis, and sourcing... more for priority area of business need, identifying, scoring and diligencing 75+ companies for partnership and M&A consideration
• Established landmark partnership with Otsuka Pharmaceutical developing r-ketamine in Japan, consisting of prospective partner identification and outreach, deal evaluation and term sheet negotiation
• Spearheaded private and public financings (convertibles, Series C, Series D, IPO) totaling over $500 million, including equity storytelling and materials development, investor marketing, and closing
• Launched public market Investor Relations function to encompass coverage from 13 analysts, robust schedule of 100+ non-deal roadshows, tiered investor strategy, and hiring of two new employees
• Led market landscaping, buy-vs.-partner analysis, and sourcing... more for priority area of business need, identifying, scoring and diligencing 75+ companies for partnership and M&A consideration
• Established landmark partnership with Otsuka Pharmaceutical developing r-ketamine in Japan, consisting of prospective partner identification and outreach, deal evaluation and term sheet negotiation
• Spearheaded private and public financings (convertibles, Series C, Series D, IPO) totaling over $500 million, including equity storytelling and materials development, investor marketing, and closing
• Launched public market Investor Relations function to encompass coverage from 13 analysts, robust schedule of 100+ non-deal roadshows, tiered investor strategy, and hiring of two new employees
